The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Third-Party Clinical Laboratory is an independent laboratory that provides testing services for medical and healthcare providers. These laboratories are not directly affiliated with a hospital or clinic, but rather operate as separate entities.
Global Third-Party Clinical Laboratory market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Third-Party Clinical Laboratory market research.
Key companies engaged in the Third-Party Clinical Laboratory industry include QUEST, LABCORP, Adicon, Kindstar Globalgene, Siemens AG, Sonic Healthcare Limited, Dian Diagnostics Group, Medicalsystem Biotechnology and BGI Genomics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Third-Party Clinical Laboratory were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Third-Party Clinical Laboratory market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Third-Party Clinical Laboratory market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- QUEST
- LABCORP
- Adicon
- Kindstar Globalgene
- Siemens AG
- Sonic Healthcare Limited
- Dian Diagnostics Group
- Medicalsystem Biotechnology
- BGI Genomics
- Hybribio Biotech
- Daan Gene
- Kingmed Diagnostics Group
Segment by Type
- Large-Scale General Inspection Laboratory
- Specialized Special Inspection Laboratory
Segment by Application
- Hospitals
- Health Care Institution
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
- Latin America (Mexico, Brazil, Rest of Latin America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
The Third-Party Clinical Laboratory report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Third-Party Clinical Laboratory Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Large-Scale General Inspection Laboratory
1.2.3 Specialized Special Inspection Laboratory
1.3 Market by Application
1.3.1 Global Third-Party Clinical Laboratory Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Health Care Institution
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Third-Party Clinical Laboratory Market Perspective (2018-2029)
2.2 Third-Party Clinical Laboratory Growth Trends by Region
2.2.1 Global Third-Party Clinical Laboratory Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Third-Party Clinical Laboratory Historic Market Size by Region (2018-2023)
2.2.3 Third-Party Clinical Laboratory Forecasted Market Size by Region (2024-2029)
2.3 Third-Party Clinical Laboratory Market Dynamics
2.3.1 Third-Party Clinical Laboratory Industry Trends
2.3.2 Third-Party Clinical Laboratory Market Drivers
2.3.3 Third-Party Clinical Laboratory Market Challenges
2.3.4 Third-Party Clinical Laboratory Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Third-Party Clinical Laboratory Players by Revenue
3.1.1 Global Top Third-Party Clinical Laboratory Players by Revenue (2018-2023)
3.1.2 Global Third-Party Clinical Laboratory Revenue Market Share by Players (2018-2023)
3.2 Global Third-Party Clinical Laboratory Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Third-Party Clinical Laboratory Revenue
3.4 Global Third-Party Clinical Laboratory Market Concentration Ratio
3.4.1 Global Third-Party Clinical Laboratory Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Third-Party Clinical Laboratory Revenue in 2022
3.5 Third-Party Clinical Laboratory Key Players Head office and Area Served
3.6 Key Players Third-Party Clinical Laboratory Product Solution and Service
3.7 Date of Enter into Third-Party Clinical Laboratory Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Third-Party Clinical Laboratory Breakdown Data by Type
4.1 Global Third-Party Clinical Laboratory Historic Market Size by Type (2018-2023)
4.2 Global Third-Party Clinical Laboratory Forecasted Market Size by Type (2024-2029)
5 Third-Party Clinical Laboratory Breakdown Data by Application
5.1 Global Third-Party Clinical Laboratory Historic Market Size by Application (2018-2023)
5.2 Global Third-Party Clinical Laboratory Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Third-Party Clinical Laboratory Market Size (2018-2029)
6.2 North America Third-Party Clinical Laboratory Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Third-Party Clinical Laboratory Market Size by Country (2018-2023)
6.4 North America Third-Party Clinical Laboratory Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Third-Party Clinical Laboratory Market Size (2018-2029)
7.2 Europe Third-Party Clinical Laboratory Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Third-Party Clinical Laboratory Market Size by Country (2018-2023)
7.4 Europe Third-Party Clinical Laboratory Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Third-Party Clinical Laboratory Market Size (2018-2029)
8.2 Asia-Pacific Third-Party Clinical Laboratory Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Third-Party Clinical Laboratory Market Size by Region (2018-2023)
8.4 Asia-Pacific Third-Party Clinical Laboratory Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Third-Party Clinical Laboratory Market Size (2018-2029)
9.2 Latin America Third-Party Clinical Laboratory Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Third-Party Clinical Laboratory Market Size by Country (2018-2023)
9.4 Latin America Third-Party Clinical Laboratory Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Third-Party Clinical Laboratory Market Size (2018-2029)
10.2 Middle East & Africa Third-Party Clinical Laboratory Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Third-Party Clinical Laboratory Market Size by Country (2018-2023)
10.4 Middle East & Africa Third-Party Clinical Laboratory Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 QUEST
11.1.1 QUEST Company Detail
11.1.2 QUEST Business Overview
11.1.3 QUEST Third-Party Clinical Laboratory Introduction
11.1.4 QUEST Revenue in Third-Party Clinical Laboratory Business (2018-2023)
11.1.5 QUEST Recent Development
11.2 LABCORP
11.2.1 LABCORP Company Detail
11.2.2 LABCORP Business Overview
11.2.3 LABCORP Third-Party Clinical Laboratory Introduction
11.2.4 LABCORP Revenue in Third-Party Clinical Laboratory Business (2018-2023)
11.2.5 LABCORP Recent Development
11.3 Adicon
11.3.1 Adicon Company Detail
11.3.2 Adicon Business Overview
11.3.3 Adicon Third-Party Clinical Laboratory Introduction
11.3.4 Adicon Revenue in Third-Party Clinical Laboratory Business (2018-2023)
11.3.5 Adicon Recent Development
11.4 Kindstar Globalgene
11.4.1 Kindstar Globalgene Company Detail
11.4.2 Kindstar Globalgene Business Overview
11.4.3 Kindstar Globalgene Third-Party Clinical Laboratory Introduction
11.4.4 Kindstar Globalgene Revenue in Third-Party Clinical Laboratory Business (2018-2023)
11.4.5 Kindstar Globalgene Recent Development
11.5 Siemens AG
11.5.1 Siemens AG Company Detail
11.5.2 Siemens AG Business Overview
11.5.3 Siemens AG Third-Party Clinical Laboratory Introduction
11.5.4 Siemens AG Revenue in Third-Party Clinical Laboratory Business (2018-2023)
11.5.5 Siemens AG Recent Development
11.6 Sonic Healthcare Limited
11.6.1 Sonic Healthcare Limited Company Detail
11.6.2 Sonic Healthcare Limited Business Overview
11.6.3 Sonic Healthcare Limited Third-Party Clinical Laboratory Introduction
11.6.4 Sonic Healthcare Limited Revenue in Third-Party Clinical Laboratory Business (2018-2023)
11.6.5 Sonic Healthcare Limited Recent Development
11.7 Dian Diagnostics Group
11.7.1 Dian Diagnostics Group Company Detail
11.7.2 Dian Diagnostics Group Business Overview
11.7.3 Dian Diagnostics Group Third-Party Clinical Laboratory Introduction
11.7.4 Dian Diagnostics Group Revenue in Third-Party Clinical Laboratory Business (2018-2023)
11.7.5 Dian Diagnostics Group Recent Development
11.8 Medicalsystem Biotechnology
11.8.1 Medicalsystem Biotechnology Company Detail
11.8.2 Medicalsystem Biotechnology Business Overview
11.8.3 Medicalsystem Biotechnology Third-Party Clinical Laboratory Introduction
11.8.4 Medicalsystem Biotechnology Revenue in Third-Party Clinical Laboratory Business (2018-2023)
11.8.5 Medicalsystem Biotechnology Recent Development
11.9 BGI Genomics
11.9.1 BGI Genomics Company Detail
11.9.2 BGI Genomics Business Overview
11.9.3 BGI Genomics Third-Party Clinical Laboratory Introduction
11.9.4 BGI Genomics Revenue in Third-Party Clinical Laboratory Business (2018-2023)
11.9.5 BGI Genomics Recent Development
11.10 Hybribio Biotech
11.10.1 Hybribio Biotech Company Detail
11.10.2 Hybribio Biotech Business Overview
11.10.3 Hybribio Biotech Third-Party Clinical Laboratory Introduction
11.10.4 Hybribio Biotech Revenue in Third-Party Clinical Laboratory Business (2018-2023)
11.10.5 Hybribio Biotech Recent Development
11.11 Daan Gene
11.11.1 Daan Gene Company Detail
11.11.2 Daan Gene Business Overview
11.11.3 Daan Gene Third-Party Clinical Laboratory Introduction
11.11.4 Daan Gene Revenue in Third-Party Clinical Laboratory Business (2018-2023)
11.11.5 Daan Gene Recent Development
11.12 Kingmed Diagnostics Group
11.12.1 Kingmed Diagnostics Group Company Detail
11.12.2 Kingmed Diagnostics Group Business Overview
11.12.3 Kingmed Diagnostics Group Third-Party Clinical Laboratory Introduction
11.12.4 Kingmed Diagnostics Group Revenue in Third-Party Clinical Laboratory Business (2018-2023)
11.12.5 Kingmed Diagnostics Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
